HEALTH CARE SURROGATE-POLST
SB1411 amends the Illinois Living Will Act to clarify when a living will declaration is operative and how it interacts with other advance directive tools. The bill adds a new applicability section stating that if a patient has a health care agency under the Illinois Power of Attorney Act, that agency controls the applicability of the Living Will Act, and a living will declaration is not operative while an authorized agent is available to make decisions about life-sustaining or death-delaying procedures. It also states that the Act does not impair the authority of a health care agent or surrogate decision maker under other laws.
The bill further adds a new section defining when a living will becomes operative: it must be validly executed, not revoked, the patient must be unable to direct treatment, and the patient must be a qualified patient. It also preserves existing protections that the withholding or withdrawal of death-delaying procedures is not suicide, that life insurance cannot be impaired by compliance with the Act, and that no provider or insurer may require a declaration as a condition of coverage or care. The bill also expressly allows declarations and related documents to be created, signed, or revoked electronically, and it prohibits providers from requiring a POLST or similar form before honoring a qualified patient’s declaration.
In practical terms, the bill affects the Illinois Living Will Act, the Power of Attorney Act, and related end-of-life decision-making practices by prioritizing health care agents and surrogate decision makers when they are available. It also reinforces the legal status of advance directives, including out-of-state declarations, and modernizes the statute by recognizing electronic formats and electronic signatures. Health care providers, facilities, insurers, patients, and agents are the primary parties affected.
The overall sentiment around the bill appears strongly supportive and noncontroversial. It passed the Illinois Senate 54-0 and the Illinois House 112-0, indicating unanimous bipartisan approval in both chambers. The absence of committee transcript debate also suggests the measure was viewed as a technical or clarifying update rather than a contested policy change.
The main points of potential contention, based on the text, are limited and mostly structural rather than ideological. The bill clarifies the relationship between living wills, health care powers of attorney, and surrogate decision-making authority, which could matter in cases where multiple advance directives exist or where a provider seeks a POLST form. It also explicitly rejects any interpretation that the Act authorizes mercy killing or creates a presumption about a person’s wishes absent a declaration, but no recorded opposition appears in the available materials.
SB1411 amends the Illinois Living Will Act by adding new statutory sections and revising Section 9 to clarify the hierarchy and operation of advance directives. It limits when a living will declaration is operative if a health care agent or surrogate decision maker is authorized to act, and it confirms that the Act does not override authority granted under the Illinois Power of Attorney Act or the Health Care Surrogate Act. It also authorizes electronic creation, signing, and revocation of documents under the Act, and prohibits requiring a POLST or similar form as a condition for honoring a qualified patient’s declaration. These changes primarily affect end-of-life care decision-making, hospitals, physicians, health care facilities, insurers, and patients with advance directives.
The bill appears to have been received very positively and without meaningful opposition. It passed both chambers unanimously, 54-0 in the Senate and 112-0 in the House, which suggests broad bipartisan agreement. With no committee transcript available showing debate or objections, the measure seems to have been treated as a clarifying and modernization bill for advance directives and end-of-life care rather than a controversial policy shift.
There is little evidence of active contention in the available record. The only substantive issues visible in the text are the bill’s clarification that a living will does not control when an authorized health care agent is available, its prohibition on requiring a POLST form before honoring a declaration, and its express preservation of provider and surrogate authority under other statutes. Those provisions could matter in practice to health care providers, facilities, and advocates for patient autonomy, but no recorded opposition or split vote appears in the legislative history provided.